Stockreport

Retail investors account for 55% of Galectin Therapeutics Inc.'s (NASDAQ:GALT) ownership, while insiders account for 21% [Yahoo! Finance]

Galectin Therapeutics Inc.  (GALT) 
Last galectin therapeutics inc. earnings: 11/12 08:00 am Check Earnings Report
PDF 44% of the business is held by the top 25 shareholders Insiders have bought recently Every investor in Galectin Therapeutics Inc. ( NASDAQ:GALT ) should be aware of [Read more]